Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;51(10):3368-73.
doi: 10.1128/JCM.01277-13. Epub 2013 Aug 7.

Bacterial floras and biofilms of malignant wounds associated with breast cancers

Affiliations

Bacterial floras and biofilms of malignant wounds associated with breast cancers

Isabelle Fromantin et al. J Clin Microbiol. 2013 Oct.

Abstract

The risk of infections and the appearance of symptoms (e.g., odors) represent the main troubles resulting from malignant wounds. The aim of this study was to characterize the balance of bacterial floras and the relationships between biofilms and bacteria and the emergence of symptoms. Experimental research was carried out for 42 days on malignant wounds associated with breast cancer. Investigations of bacterial floras (aerobes, aero-anaerobes, and anaerobes), detection of the presence of biofilms by microscopic epifluorescence, and clinical assessment were performed. We characterized biofilms in 32 malignant wounds associated with breast cancer and bacterial floras in 25 such wounds. A mixed group of floras, composed of 54 different bacterial types, was identified, with an average number per patient of 3.6 aerobic species and 1.7 anaerobic species; the presence of strict anaerobic bacterial strains was evidenced in 70% of the wounds; biofilm was observed in 35% of the cases. Odor was a reliable indicator of colonization by anaerobes, even when this symptom was not directly linked to any of the identified anaerobic bacteria. Bacteria are more likely to be present during myelosuppression and significantly increase the emergence of odors and pain when present at amounts of >10(5) · g(-1). The presence of biofilms was not associated with clinical signs or with precise types of bacteria. No infections occurred during the 42-day evaluation period. This study provides a dynamic description of the bacterial floras of tumoral wounds. The study results highlight the absolute need for new therapeutic options that are effective for use on circulating bacteria as well as on bacteria organized in biofilm.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Relative frequencies of the numbers of different aerobic (formula image) and anaerobic (□) species per patient as observed on day 21.
Fig 2
Fig 2
Impact of the presence of strict anaerobes (A) and the numbers of bacterial species (B, C) on various symptoms. (A) Impact of the presence of strict anaerobic species on odors (no odor, formula image; odor from weak to strong, □). (B) Impact of bacterial species number on odors (no odor, formula image; odor from weak to strong, □). (C) Impact of bacterial species number on exudates (no/weak exudate, formula image; moderate/strong exudate, □).
Fig 3
Fig 3
Impact of bacterial load on symptoms. (A) Impact of bacterial load on odor intensity (no odor, □; weak odor, formula image; moderate odor, formula image; strong odor, ■) (P = 0.56). (B) Impact of bacterial load on exudates (no exudate, □; weak exudate, formula image; moderate exudate, formula image; strong exudate, ■) (P = 0.07). (C) Impact of bacterial load on pain (no pain, □; weak pain, formula image; moderate pain, ▩; strong pain, formula image; intense pain, ■) (P = 0.04).
Fig 4
Fig 4
Biofilm identification on tumoral wounds using epifluorescence microscopy. Samples were stained with lectins coupled to fluorochromes and DAPI. Samples of patients 1 and 2, lectins Bandeiraea simplicifolia-tetramethylrhodamine isothiocyanate (TRITC) and Lycopersicon esculentum-fluorescein isothiocyanate (FITC); samples of patients 6 and 7, lectins Arachis hypogaea-TRITC and Lycopersicon esculentum-FITC.

References

    1. Grocott P. 1999. The management of fungating wounds. J. Wound Care 8:232–234 - PubMed
    1. McMurray V. 2003. Managing patients with fungating malignant wounds. Nurs. Times 99:55–57 - PubMed
    1. Langemo DK, Anderson J, Hanson D, Hunter S, Thompson P. 2007. Managing fungating wounds. Adv. Skin Wound Care 20:312–314 - PubMed
    1. Meaume S, Kerihuel JC, Fromantin I, Teot L. 2012. Workload and prevalence of open wounds in the community: French Vulnus initiative. J. Wound Care 21:62–73 - PubMed
    1. Probst S, Arber A, Faithfull S. 2009. Malignant fungating wounds: a survey of nurses' clinical practice in Switzerland. Eur. J. Oncol. Nurs. 13:295–298 - PubMed

Publication types

LinkOut - more resources